An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Administered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period November 1, 2019 J Clin Aesthet Dermatol. 2019;12(11):13–18 by James Q. Del Rosso, MD; Linda CONTINUE READING »
